The NavDx® test is the first and most clinically validated liquid biopsy test for early detection of HPV+ cancer recurrence. NavDx is now part of CareDx, expanding precision diagnostics into specialty oncology. Follow CareDx for the latest updates: www.navdx.com www.caredx.com
| Website | http://www.navdx.com |
| Employees | 88 (80 on RocketReach) |
| Founded | 2017 |
| Address | 21 Hickory Drive Suite 600, Waltham, Massachusetts 02451, US |
| Phone | +1 833-628-3747 |
| Technologies |
JavaScript
,
HTML
,
PHP
+28 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care |
| Keywords | Molecular Diagnostics, Early Cancer Detection, Blood Tests, Cancer Diagnostics, Novel Diagnostics, Liquid Biopsy, Oncology Diagnostics, Molecular Testing, Clinical Management, Precision Oncology, Diagnostic Testing, Viral Detection, Biomarkers, Cancer Research, Medical Diagnostics, In Vitro Diagnostics, Disease Diagnostics, Health Diagnostics |
Looking for a particular NAVERIS employee's phone or email?
Barry Berger is the Chief Medical Officer of NAVERIS.
80 people are employed at NAVERIS.
NAVERIS is based in Waltham, Massachusetts.